Iovance stock drops nearly 10% following snag with FDA over experimental melanoma treatment

The California biotech company is building a cell therapy production plant at the Philadelphia Navy Yard.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.